Kheiron
London, GB · 2 known investors
Kheiron Medical Technologies developed AI-powered breast cancer diagnostic tools, including Mia™, which assisted radiologists in breast screening decision-making. The company was acquired by DeepHealth in 2024 and its technology now supports SmartMammo™, an AI solution for breast cancer diagnostic workflows.
AI & Machine LearningHealthtechMedical Devices